U.S. Electric Utilities Stock News

Avantor recently announced that Simon Dingemans, a veteran executive with senior roles at GSK, Goldman Sachs and Carlyle, will join its Board of Directors effective January 2, 2026. This appointment brings additional healthcare, finance and corporate governance expertise to Avantor at a time when its competitive positioning and disclosures are under scrutiny from multiple securities class action lawsuits. We’ll now examine how the addition of Simon Dingemans to Avantor’s board shapes the...

Recently, Alaska Air Group lowered its fourth-quarter earnings outlook amid operational headwinds, while also announcing new 2026 route additions from Anchorage, Portland, and Seattle Paine Field that broaden its domestic and long-haul international network. Alongside these network moves, the company is investing in Hawai'i-produced sustainable aviation fuel and elevating safety leadership, signaling a focus on long-term efficiency and risk management even as near-term profit expectations...

Earlier this year, Getty Realty Corp. reported stronger-than-expected quarterly results, raising its AFFO guidance while maintaining portfolio occupancy at 99.8% and highlighting an almost 7% dividend yield. The combination of higher cash-flow guidance, accelerated investment activity, and a balance sheet with low leverage and no major debt due until 2028 underscored the REIT’s income resilience and financial flexibility. We’ll now explore how Getty’s raised AFFO guidance and stronger...

Peloton Interactive recently posted quarterly results showing a 6% year-on-year revenue decline but beating market expectations on revenue, EPS, and adjusted operating income, while management emphasized disciplined execution ahead of new product launches like Peloton IQ. Despite this operational progress, analysts have responded cautiously, with several reiterating Hold or Neutral ratings as they factor in higher churn, softer full-year guidance, and ongoing retail sector challenges. We’ll...

Recently, LCI Industries received a top Zacks Rank of #1 as analysts raised full-year earnings estimates by 12.8% over the past 90 days, supported by a year-to-date performance that has outpaced the broader Auto-Tires-Trucks sector. This upgrade builds on LCI Industries' consistent record of beating earnings expectations and valuation metrics that many investors view as attractive for value-focused exposure within auto components. With analyst earnings estimates moving higher and reinforcing...

If you are wondering whether Coty is a beaten down value opportunity or a value trap at today’s price, this article will walk you through what the numbers really say. The stock has barely budged in the short term, up 1.2% over the past week and just 0.3% over the last month. However, zooming out shows a much rougher ride, with the share price down 52.5% year to date and 53.7% over the last year. Those steep longer term declines reflect a mix of investor concerns around the pace of Coty’s...

Earlier in December 2025, Dyne Therapeutics reported positive topline results from the Registrational Expansion Cohort of its Phase 1/2 DELIVER trial, showing z-rostudirsen increased muscle content-adjusted dystrophin expression to 5.46% of normal in Duchenne muscular dystrophy patients amenable to exon 51 skipping. Alongside these data, Dyne completed a US$350.00 million follow-on common stock offering, reinforcing its financial capacity to advance z-rostudirsen and related...

In December 2025, Vita Coco, America’s leading coconut water brand, announced a partnership making it the Official Hydration Partner of Rush Soccer, bringing its naturally hydrating drinks to tournaments, hydration stations, and grassroots events across one of the world’s largest youth soccer communities starting in 2026. This collaboration gives Vita Coco direct, recurring exposure to young athletes and their families at organized events, potentially reinforcing its positioning as a cleaner...

In 2025, Chagee Holdings released its inaugural 2024 Sustainability Report and continued expanding across Asia Pacific, now operating over 7,338 tea houses in markets including Indonesia, the Philippines, Vietnam, Singapore, Malaysia, and Thailand. By pairing ESG-focused initiatives with health certifications and culturally tailored product innovation, the company is positioning its modern tea brand to appeal to both socially conscious and health-oriented consumers across the region. We’ll...

Earlier this month, Taylor Morrison Home’s board appointed Klaviyo Chief Financial Officer Amanda Whalen as an independent director and Audit Committee member, recognizing her as an “audit committee financial expert” effective March 1, 2026. Her background in finance leadership at Klaviyo, Walmart, and Bain brings additional financial oversight experience as Taylor Morrison contends with weaker demand, shrinking backlog, and pressure on homebuilding margins. We’ll now examine how Whalen’s...

Earlier this month, Kyndryl introduced a Quantum Safe Assessment service that maps cryptographic risks across enterprise IT estates and builds post-quantum security roadmaps, while also rolling out AI-powered services for IBM z/OS and a broader Agentic AI Digital Trust framework for managing AI across hybrid and multi-cloud environments. Together, these launches underscore Kyndryl’s effort to become a go-to partner for addressing emerging threats in encryption, AI governance, and digital...

Insperity (NSP) just gave itself more financial breathing room by amending its credit agreement to lift revolving capacity to $750 million, with room to reach $800 million, and pushing the maturity out to 2028. See our latest analysis for Insperity. The expanded credit line arrives after a volatile stretch, with a strong 1 month share price return of 21.84% coming off a much weaker year to date share price return of 48.87% and a 3 year total shareholder return of 63.24%. This suggests recent...

Brixmor Property Group (BRX) has been drifting lower this year, even though its shopping center portfolio keeps generating steady revenue growth. That disconnect between fundamentals and share performance is what makes the stock interesting now. See our latest analysis for Brixmor Property Group. At around $25.77, Brixmor’s share price has eased back over the year, yet its five year total shareholder return of roughly 98 percent shows long term investors have still been well rewarded. This...

Vicor (VICR) just caught investors attention after Roth Capital initiated coverage with a fresh buy rating, helping push the stock higher on the back of already strong recent earnings momentum. See our latest analysis for Vicor. That fresh buy call comes after a powerful run, with a 1 month share price return of about 23 percent and a roughly 97 percent 3 month share price return. The 1 year total shareholder return above 110 percent indicates that momentum has been building rather than...

Cogent Biosciences (COGT) just delivered another important clinical update, with positive APEX Part 2 results in advanced systemic mastocytosis and full SUMMIT data in nonadvanced disease, reinforcing bezuclastinib as its core value driver. See our latest analysis for Cogent Biosciences. Those back to back APEX and SUMMIT wins help explain why Cogent’s 90 day share price return is 230.41% and its 1 year total shareholder return sits at 404.46%, suggesting bullish momentum rather than a one...

KKR recently released its “High Grading” 2026 Global Macro Outlook and announced fresh capital commitments, including a US$1 billion expansion of its clean energy co-investment platform with HASI and a US$220 million growth investment in quantitative analytics firm Premialab. Taken together with ongoing portfolio moves in infrastructure, renewables and education, these steps underline how KKR is leaning into long-term thematic opportunities across sustainable infrastructure and data-driven...

Goldman Sachs recently initiated coverage of MBX Biosciences with a Sell rating, citing concerns about the company’s ability to validate its platform beyond lead candidate canvuparatide and the potential differentiation of upcoming post-bariatric hypoglycemia data expected in 2026. At the same time, MBX Biosciences is moving its endocrine and metabolic pipeline toward later-stage development, including Phase 3 planning for canvuparatide and increased visibility through events such as the...

Earlier this month, Owlet, Inc. announced a new DME partnership with 1 Natural Way, allowing families across the U.S. to access its FDA-cleared BabySat pulse oximeter through insurance-supported channels, including commercial plans, many state Medicaid networks, and TRICARE. This expansion into reimbursed home monitoring for higher-risk infants underlines Owlet’s push further into clinically integrated, insurance-backed distribution rather than relying solely on direct-to-consumer...

Williams-Sonoma (WSM) just gave income-focused investors something to smile about, with its board affirming a quarterly cash dividend of $0.66 per share, a move that underscores management’s confidence in its future earnings power. See our latest analysis for Williams-Sonoma. The dividend news comes after a solid run, with a roughly 9 percent 1 month share price return and a powerful 3 year total shareholder return of about 236 percent, suggesting momentum is still broadly intact. If that...

Nurix Therapeutics, Inc. recently presented new clinical data from its ongoing Phase 1a/1b NX-5948-301 trial of bexobrutideg (NX-5948) in relapsed or refractory B-cell malignancies at the 67th American Society of Hematology Annual Meeting, including safety and efficacy findings across multiple dose levels and patient cohorts. The data underpin selection of a 600 mg dose as the recommended Phase 2 level and support Nurix’s pivotal DAYBreak development program under FDA initiatives Project...

In the recent past, YETI Holdings reported a third quarter in which revenue and EBITDA came in ahead of analyst expectations, with management crediting product innovation, brand strength, and expanding international reach for the performance. This combination of stronger-than-expected results and confident growth commentary suggests that YETI’s long-term expansion efforts may be gaining meaningful operational traction. Now we’ll examine how YETI’s better-than-expected quarterly performance...

Earlier this week, Sardine announced a partnership with Helix by Q2, integrating real-time fraud monitoring and compliance tools into Q2’s cloud-native embedded finance platform for sponsor banks and fintech clients. This tie-up strengthens Q2’s risk-management offering, potentially making its digital banking and embedded finance stack more attractive to regulated institutions seeking end-to-end fraud and compliance capabilities. We’ll now explore how this enhanced fraud and compliance...

If you are wondering whether Bitmine Immersion Technologies at around $31 a share is still a smart bet after its huge run, or if the easy money has already been made, you are not alone. The stock is down about 10% over the last week but still up 7.5% in the past month, with an eye catching 348.0% gain year to date and 282.6% over the last year, a combination that highlights both potential opportunity and elevated risk. Much of this move has coincided with growing market attention on...

H&R Block (HRB) just turned in a quarter that topped revenue and EBITDA expectations, then followed it up with the biggest full year guidance raise in its peer group. This signals management’s confidence heading into fiscal 2026. See our latest analysis for H&R Block. The upbeat outlook lands after a choppy stretch for the stock, with a 90 day share price return of minus 13.05 percent and a year to date share price return of minus 17.67 percent, yet the five year total shareholder return of...